About AgeneBio

Company Website: http://agenebio.com

AgeneBio is a neuroscience pharmaceutical company founded by Dr Michela Gallagher in 2008 that is focused on developing treatments for diseases that impact memory. The initial therapeutic targets are Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's disease (AD). The company is headquartered in Indianapolis but conducts research and development work on a global basis utilizing partner relationships.


Current Openings

AgeneBio has no jobs listed. Checkout our job board for opportunities at top VC-backed startups.